Results 191 to 200 of about 585,525 (398)
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo+22 more
wiley +1 more source
Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass [PDF]
Study purpose - assessment of the relationship of levels of aldosterone and natriuretic peptide plasma aldosterone synthase gene polymorphism variants in patients with coronary heart disease (CHD) in combination with arterial hypertension (AH) at ...
D A Yahontov+2 more
doaj
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis+8 more
wiley +1 more source
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt+18 more
wiley +1 more source
9 ASSESSMENT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE ADOLESCENTS USING ECHO, ECG, AND X-RAY [PDF]
W. Pennock Laird+2 more
openalex +1 more source
Heart failure (HF) with supranormal ejection fraction (HFsnEF) is an unnoticed but emerging entity in HF. This study showed that HFsnEF carries a similarly increased cardiovascular risk as HF with reduced ejection fraction (HFrEF) and distinct structural and proteomic characteristics from HFrEF, warranting a further comprehensive understanding and ...
Yasuhiko Sakata+19 more
wiley +1 more source
Serial blood pressure measurements, left ventricular remodelling and cardiovascular outcomes
We assessed systolic blood pressure (BP), diastolic BP and pulse pressure at several time points during adulthood in 2544 subjects participating in the Akershus Cardiac Examination 1950 Study. Serial blood pressure measurements are strongly associated with indexed LV mass, LV systolic function, and LV volumes, as well as risk of incident myocardial ...
Magnus Nakrem Lyngbakken+9 more
wiley +1 more source
Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements. [PDF]
Gen Shimizu+3 more
openalex +1 more source
Lipidome changes in anthracycline‐induced cardiotoxicity (AIC). Aims Anthracyclines are key components of various chemotherapy regimens, but their clinical utility is limited by severe cardiotoxic side effects. Previous studies have suggested that anthracycline‐induced cardiotoxicity (AIC) may be driven by alterations in myocardial lipid metabolism ...
Vera M. Braun+6 more
wiley +1 more source
Correlation between left ventricular hypertrophy and diastolic dysfunction in arterial hypertension
Aim. To evaluate relationships between arterial pressure (AP), myocardial mass of the left ventricle (LVMM) and left ventricular diastolic function (LVDF) in patients with hypertension stage I and II. Material and methods. 89 hypertensive patients and 30
Z К Trushinsky+2 more
doaj